Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders

NARecruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

June 1, 2026

Conditions
Bipolar DisorderNon-Adherence, MedicationHypertensionMajor Depressive Disorder
Interventions
BEHAVIORAL

iTAB-CV

Individualized Texting for Adherence Building - Cardiovascular (iTAB-CV): a personalized patient-centered text message-based adherence intervention

BEHAVIORAL

Self-Monitoring

The Self-Monitoring (control) group will monitor their medication adherence, take their blood pressure weekly with a home blood pressure monitor provided by the study after being trained by the study staff, and rate their mood weekly in response to a text reminder.

Trial Locations (1)

44106

RECRUITING

Case Western Reserve University, Cleveland

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Case Western Reserve University

OTHER